Our results provide direct evidence for a physiological role of TRPV4TM-eNOS signaling and indicate that impaired TRPV4TM-eNOS signaling may underlie TM dysfunction and IOP dysregulation in glaucoma. This evidence concerns the gene NOS3 and glaucoma.